This study identified a TSC2 intron variant (c.2742+5G>A), confirmed its pathogenicity in a family with TSC, and compared the splicing analyses results obtained from six prediction tools, minigene assay, and patients' lymphocyte mRNA. Here, TSC2 is linked to tuberous sclerosis.